5don MSN
Cancer rates are rising in CT young people. Here’s what doctors say and what you should know
Breta Hasimi struggled to speak when she received the diagnosis of triple-negative breast cancer, one of the most aggressive ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, Baystreet.ca News Commentary, The global oncology and cancer drugs market, valued at $167 billion in 2023, is projected to reach $335.2 billion ...
USA News Group News Commentary, The global oncology market is on track to nearly triple in value over the next decade, growing from $279.98 billion in 2026 to an estimated $748.17 billion by 2035[1].
ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...
Spin-off of biopharma operations into a public company to be called "First Tracks Biotherapeutics" on track for Q2 2026, potentially as early as late-AprilPhase 1b enrollment ongoing in celiac disease ...
New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO beyond lung ...
Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence ...
Dr. Shikha Jain breaks down new data showing colorectal cancer cases declining in adults over 65 but climbing sharply in ...
Colorectal cancer is now the No. 1 cancer killer for adults under 50, an American Cancer Society report found. The report ...
Colorectal cancer is now the No. 1 cancer killer for adults under 50, an American Cancer Society report found. The report more closely examines the increase in colorectal cancer rates in people under ...
After decades of decline, rates of rectal cancer have risen by about 1 percent each year from 2018 to 2022. Rectal cancer, which originates in the last 12 to 15 centimeters of the large intestine, now ...
A colorectal cancer diagnosis in people under the age of 50 can come as a shock. Even more surprising is that rates of colorectal cancer are rising among younger individuals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results